إعلان
إعلان

ENSC

ENSC logo

Ensysce Biosciences, Inc. Common Stock

1.01
USD
برعاية
-0.05
-4.81%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
exchange

بعد الإغلاق

1.00

0.00
-0.40%

تقارير أرباح ENSC

النسبة الإيجابية المفاجئة

ENSC تفوق 11 من 16 آخر التقديرات.

69%

التقرير التالي

بيانات التقرير القادم
٠٩ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$510.00K
/
-$1.28
التغير الضمني من Q3 25 (Revenue/ EPS)
+3.45%
/
-0.78%
التغير الضمني من Q4 24 (Revenue/ EPS)
-60.89%
/
-55.86%

Ensysce Biosciences, Inc. Common Stock earnings per share and revenue

On ١٤ نوفمبر ٢٠٢٥, ENSC reported earnings of -1.29 USD per share (EPS) for Q3 25, missing the estimate of -0.88 USD, resulting in a -46.21% surprise. Revenue reached 493.00 ألف, compared to an expected 714.00 ألف, with a -30.95% difference. The market reacted with a -4.85% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of -1.28 USD, with revenue projected to reach 510.00 ألف USD, implying an نقصان of -0.78% EPS, and زيادة of 3.45% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Ensysce Biosciences, Inc. Common Stock reported EPS of -$1.29, missing estimates by -46.21%, and revenue of $493.00K, -30.95% below expectations.
The stock price moved down -4.85%, changed from $2.06 before the earnings release to $1.96 the day after.
The next earning report is scheduled for ٠٩ مارس ٢٠٢٦.
Based on 3 المحللين, Ensysce Biosciences, Inc. Common Stock is expected to report EPS of -$1.28 and revenue of $510.00K for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان